Trust and transparency
Editorial standards
Last updated
The sources we accept
Our standard is primary sources first. In order of preference:
- Federal regulators and agencies: the FDA, the DEA, and the NIH, including ClinicalTrials.gov.
- State health authorities that run or regulate programs.
- Peer-reviewed journals, preferring randomized controlled trials, systematic reviews and meta-analyses.
Some facts are not published by any of these. When that happens we use the best available source and say plainly what it is:
- Trial sponsors and research organizations. For where a drug stands in development, such as a trial result or regulatory filing that has been announced but not yet published in a journal, we may cite the sponsor's own announcement. We name it as a company or sponsor announcement and do not treat it as independent evidence that a treatment works.
- Price surveys. No government agency publishes what cash-pay treatment costs. For typical prices we cite published price surveys and marketplaces, name them, and label the figures as estimates.
We do not use clinic marketing, social media, or news coverage as the basis for a medical or legal claim. News may point us to a source; the source is what we cite.
How we write
Answer first, then explain. Each section opens with a direct answer in plain English, followed by context. We name what is unknown as clearly as what is known, and we separate "has been studied for" from "has been shown to work for".
Checking facts
- The sources behind statements about approval, legality, evidence, risk and cost are listed with each treatment and in a full source list on the page.
- Each fact set carries a visible "verified on" date, so you can judge how fresh it is.
- Costs are labelled as estimates with their source; we do not invent prices.
- We do not describe personal testing, clinic visits or first-hand experience unless it actually happened, and we will say who did it when it does.
Independence
No company, clinic or advertiser can pay to appear, to be described favorably, or to review content before publication. There are no commercial relationships today. If any begin, they are disclosed under our affiliate disclosure, and editorial staff decide content without regard to them.
Responsible language
We avoid hype, urgency and promises of outcomes. We do not describe how to obtain or use substances outside legal, supervised care. Safety information and crisis resources sit beside treatment information, not buried below it.
Keeping it current
Regulation and research in this field move quickly. We re-verify facts against their sources and update the "verified on" date when we do. Material changes are logged under corrections and updates.
Related policies
- Medical Review PolicyThe evidence standards behind health content on Psychedelic Therapy Index, the sources we rely on, and the current status of clinical review.
- Corrections & UpdatesHow to report an error on Psychedelic Therapy Index, how corrections are made and labelled, and how pages are re-verified when laws or evidence change.
- Review MethodologyThe criteria Psychedelic Therapy Index will use to evaluate psychedelic therapy providers: licensing, screening and safety, support, pricing and patient rights.
- Affiliate DisclosureHow Psychedelic Therapy Index is funded, how affiliate and referral links are labelled, and why compensation never determines our conclusions.